index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

54 Publications avec texte intégral

Open Access

46 %

Mots clés

Interferon Lamin A/C nuclei Thymus Th17 cells Centres germinatifs ectopiques CCL21 MiR-125 COVID-19 Etiology Heart failure Neuromuscular junction Macrophages Gd T cells Innate immunity Inflammation Autoimmune disease Max Autoimmune diseases Adaptive immunity Myasthenia gravis Autoimmunity Acides nucléiques endogènes Clinical cell transplantation Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Chemokines Immunity Interferon type I Germinal centers Acetylcholine receptor Interleukine-23 Myoblasts Gender Human myoblasts Interféron de type I BAFF PBMC Interferon de type I MG patients Experimental autoimmune myasthenia gravis Exercise Interferon type-I LMNA Myasthenia Gravis MG Acetylcholine receptors Chemokine Ectopic germinal centers B cells Animal models COX2 Conduction disease Genetic associations AChR antibodies Antimir-150 CXCL13-CXCR5 Ferrites Immunotherapy Auto-immunité Chronicity Anticorps monoclonal Myasthénie grave Inflammatory cytokines MYB Chronic inflammation Endogenous nucleic acids Complete Freund's adjuvant Experimental autoimmune myasthenia gravis EAMG Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration DICER CTCF CD31 Interferonopathy Immune response Interferon-β Acetylcholine receptor antibodies Interleukin 23 Thymic epithelial cells Immune regulation Cardiomyopathy Il-23 FMR1 MiR-7 Cellules th17 M3243AG Fragile X syndromes Quality of life Maladie auto-immune Immunology and Microbiology Section Early-onset myasthenia gravis Thymoma Germinal center Disease susceptibility Genetics Experimental mouse models Mass cytometry CyTOF Long-term follow-up Transcriptome Experimental models Cytokines Interferon IFN Glucocorticoids